CardiAro is a state-of-the-art AI-powered Patch Holter Monitor that delivers continuous, real-time cardiac rhythm analysis with clinical-grade precision.

 

Designed to replace legacy Holter and event monitoring systems, CardiAro enables early detection of arrhythmias, ischemic events, and heart rate variability insights, supporting better outcomes in both clinical and home care environments.

Market Opportunity & Growth Potential

  • Cardiovascular disease (CVD) remains the world’s #1 cause of death, with over 523M people affected globally.

  • The ambulatory cardiac monitoring market is projected to exceed $4.5B by 2028, growing at a CAGR of 16-18%, driven by demand for remote diagnostics.

  • Wearable medical devices with cardiorespiratory monitoring capabilities are rapidly expanding, with a projected CAGR of 25.53% from 2025–2030.

  • The shift toward telehealth, preventive cardiology, and decentralized care is fueling demand for scalable, AI-integrated monitoring platforms.

  • Wearable Cardiac Hemodynamic Monitoring

  • Real Time Feedback

  • AI powered Risk Prediction of Hospitalization and death

CardiAro

CardiAro
CardiAro CardiAro

Projected Growth & Strategic Expansion

Year 1-2

Clinical trials, FDA & CE Mark approvals, deployment across clinics, cardiology practices, and telehealth platforms in North America.

Year 3-5

Expansion into GCC, Asia, Europe, and Australia with strategic partnerships in digital health, insurance, and hospital chains.

Year 5+

Expected revenue surpassing $500M, with CardiAro positioned as a category leader in next-gen AI cardiac diagnostics.

Redefining Remote Cardiac Care

 With its unmatched AI capabilities, patient-centric design, and seamless scalability, CardiAro is the future of ambulatory cardiac monitoring. In an era demanding faster, smarter, and more accessible heart health solutions, CardiAro delivers.